We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test runs on Ortho’s Vitros platform, using swab samples that can be stored at room temperature for up to two days and will become available worldwide in large supply this month. Read More
Novavax announced Wednesday that it has reached an agreement with Australia that will see the company supply 40 million doses of its COVID-19 vaccine candidate for the country. Read More
UK Vaccine Taskforce Chairwoman Kate Bingham revealed Wednesday that the country will have millions fewer doses of AstraZeneca’s vaccine candidate available by the end of the year than previously anticipated. Read More
The software can automatically detect lung abnormalities and pneumonia, providing details, such as the quantity and classification of lesions. Read More
The Coalition for Epidemic Preparedness Innovations (CEPI) has agreed to fund development of a potential COVID-19 vaccine from China’s Clover Biopharmaceuticals with a global phase 2/3 study and through licensing and distribution. Read More
Gilead Sciences says it has no plans to relinquish the Priority Review voucher it earned from the FDA’s approval of remdesivir as a COVID-19 treatment despite urging from a consumer advocacy group that argued the company is earning more than is reasonable from the antiviral. Read More
Pfizer said it intends to handle the distribution of its COVID-19 vaccine itself after the federal government’s initial distribution to priority populations is completed. Read More
A Russian drugmaker has asked the Kremlin for a compulsory license allowing it to manufacture a generic of Gilead Sciences’ antiviral drug remdesivir. Read More
German biopharma company CureVac announced yesterday that its COVID-19 vaccine hopeful generated immune responses and was generally well-tolerated in phase 1 trial participants, lending support for a pivotal trial before year’s end. Read More
A growing number of states say they don’t plan to automatically distribute FDA-approved COVID-19 vaccines to their residents. Nevada, Oregon and Washington announced last week that they plan to conduct independent verification before distributing any vaccines. Read More